The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
Abstract
Transient transfection of foreign DNA is the most widely used laboratory technique to study gene function and product. However, the transfection efficiency depends on many parameters, including DNA quantity and quality, transfection methods and target cell lines. Here, we describe the considerable advantage of mRNA electroporation compared to conventional DNA-based systems. Indeed, our methodology offers extremely high transfection efficiency up to 98% regardless of the cell line tested. Protein expression takes place a few hours post-transfection and lasts over 72 h, but overall, the electrotransfer of mRNAs enables the monitoring of the level of protein expressed by simply modulating the amount of mRNAs used. As a result, we successfully conducted cell imaging by matching the levels of expressed VHHs and the antigen present in the cell, preventing the necessity to remove the excess unbound VHHs. Altogether, our results demonstrate that mRNA electrotransfer could easily supplant the conventional DNA-based transient expression system.
Overview
CoChat Summary
TL;DR
mRNA electrotransfer achieved extremely high transfection efficiency (up to ~99–100%) across multiple cell lines, with rapid and tunable protein expression, outperforming DNA electroporation and cationic polymer delivery in this study. The authors propose mRNA electroporation as a viable substitute for conventional DNA-based transient transfection.
Key findings
- mRNA electroporation yielded approximately 100% transfection efficiency across all tested cell lines, whereas JetMESSENGER® efficiency was cell-line dependent (~80% in SiHa, 30–5% in Caski and MDA-MB231). DNA electroporation reached only 15% with 1 µg and 1.5% with 500 ng, with cell survival of ~30–50% versus ~85% for mRNA/JetMESSENGER®.
- Protein expression from electrotransferred mRNA began as early as 6 h and lasted up to 72 h; expression level was controllable by mRNA amount (e.g., nano-GFP-NLS-mScarlet optimal at 100 ng; con1-NLS-mScarlet optimal at 50–25 ng; nano-Lamin-mScarlet optimal at 200 ng early and 50–200 ng at 24 h).
- Functional validation included 16E6 mRNA reducing p53 in >99% of MDA-MB231 cells, TOX mRNA (100 ng) causing >95% cell death with an IC50 of 0.2 ± 0.03 ng, and co-electroporation of two mRNAs giving ~95% single/double transfection efficiency.
Methods
- Compared mRNA delivery by electroporation (Neon™, 1200 V, 20 ms, 1 rectangular pulse) and JetMESSENGER® cationic polymer, plus DNA electroporation, in cell lines including MDA-MB231, HCC1954, MRC-5, Caski, SiHa, NK-92, AGS, HeLa-H2B2eGFP, MRC5-EYFP-pol η, and U-2OS.
- mRNAs were synthesized by in vitro transcription from a T7 promoter, capped, poly(A)-tailed, and quality-controlled; readouts included direct/indirect immunofluorescence, flow cytometry, western blot, MTT cytotoxicity, and UV-C DNA damage.
- Main analysis assessed transfection efficiency, cell viability, protein expression/localization, mRNA titration, and functional assays (p53 degradation, toxin killing, nanobody imaging, PCNA/pol η recruitment), with statistics by one-way ANOVA and Student’s t-test on at least three independent replicates.
Limitations
- Stated in the paper: a major drawback is the requirement for meticulous operating procedures to prevent mRNA degradation during synthesis and handling.
- Evident from the text: the study is limited to cultured cancer and immortalized cell lines; no primary cells or in vivo validation are reported.
- Evident from the text: optimal mRNA amount depends on the target antigen and incubation duration, requiring titration for each application, and the DNA comparison was restricted to selected cell lines and conditions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 0 Not valid · 13 Not checked · 35 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The amount of 100 ng was optimal to visualize the distribution of H2B2 during the different steps of the cell cycle (Figure 4B) with minimal background in the cytoplasm”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 2. Results > 2.4. Nanobody Anti-GFP
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As shown in Figure 3A, transfection of 100 ng of mRNA coding for TOX was sufficient to trigger more than 95% cell death.”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 2. Results > 2.3. TOX Fragment from Pseudomonase aeruginosa
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As shown in Figure 3B, the toxin effect correlated with the amount of mRNA transfected with an IC50 of 0.2 (±0.03) ng of mRNA.”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 2. Results > 2.3. TOX Fragment from Pseudomonase aeruginosa
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the transfection efficiency with the JetMESSENGER® was particularly cell line dependent (Figure 1 and Figure S1).”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 2. Results > 2.1. High Transfection Efficiency for Various Cell Lines
plainstates an associationn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“However, when the cells were transfected with the con1-NLS-mScarlet mRNA, DNA pol η was no longer recruited to the foci (Figure 5B) as expected [27,29].”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 2. Results > 2.5. Interplay between PCNA, Con1 and DNA Polymerase η
What the sources say
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
19 more claims
Create a free account to see all 48 claims and to verify the 23 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 6
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 2. Results > 2.5. Interplay between PCNA, Con1 and DNA Polymerase η
“As shown in Figure 2B, EYFP-pol η (green signal) was detected by the nano-eGFP-NLS-mScarlet VHH that binds with high affinity to EYFP [10] (red signal) at the replication foci visualized by the strong co-localized yellow speckles (Figure 5B).”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 2. Results > 2.2. E6 Oncoprotein from HPV16
“As shown in Figure 2B, transfection of the mRNA encoding the 16E6 protein led to a strong reduction in the p53 level in more than 99% of the cells, whereas the mRNA encoding the mScarlet had no effect (control).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > Abstract
“our methodology offers extremely high transfection efficiency up to 98% regardless of the cell line tested.”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 3. Discussion
“For all constructs tested, we achieved extremely high transfection efficiencies of up to 99.0% in several cancer cell lines”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > Abstract
“Protein expression takes place a few hours post-transfection and lasts over 72 h”
§ The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection > 3. Discussion
“the expression of the protein encoded by the mRNA occurs as early as 6 h after transfection and lasts up to 72 h.”
Citations
Cites
PCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
Electroporation of cell membranes
Tsong, T. Y. (1991) · Biophysical Journal · doi:10.1016/s0006-3495(91)82054-9 · Cited by 1,094
Durocher, Y. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.2.e9 · Cited by 1,037
Targeting and tracing antigens in live cells with fluorescent nanobodies
Rothbauer, U., Zolghadr, K., Tillib, S., Nowak, D., Schermelleh, L., Gahl, A., Backmann, N., Conrath, K., Muyldermans, S., Cardoso, M. C., et al. (2006) · Nature Methods · doi:10.1038/nmeth953 · Cited by 710
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Martinez-Zapien, D., Ruiz, F. X., Poirson, J., Mitschler, A., Ramirez, J., Forster, A., Cousido-Siah, A., Masson, M., Pol, S. V., Podjarny, A., et al. (2016) · Nature · doi:10.1038/nature16481 · Cited by 483
PCNA: a silent housekeeper or a potential therapeutic target?
Wang, S.-C. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.02.004 · Cited by 285
Pseudomonas Exotoxin A: optimized by evolution for effective killing
Michalska, M., & Wolf, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00963 · Cited by 283
A Review on Electroporation-Based Intracellular Delivery
Shi, J., Ma, Y., Zhu, J., Chen, Y., Sun, Y., Yao, Y., Yang, Z., & Xie, J. (2018) · Molecules · doi:10.3390/molecules23113044 · Cited by 261
Translesion DNA polymerases in eukaryotes: what makes them tick?
Vaisman, A., & Woodgate, R. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1291576 · Cited by 249
Comparative transfection of DNA into primary and transformed mammalian cells from different lineages
Maurisse, R., De Semir, D., Emamekhoo, H., Bedayat, B., Abdolmohammadi, A., Parsi, H., & Gruenert, D. C. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-9 · Cited by 228
Transfer and Expression of Foreign Genes in Mammalian Cells
Colosimo, A., Goncz, K. K., Holmes, A. R., Kunzelmann, K., Novelli, G., Malone, R. W., Bennett, M. J., & Gruenert, D. C. (2000) · BioTechniques · doi:10.2144/00292rv01 · Cited by 187
An Overview of Methods and Tools for Transfection of Eukaryotic Cells in vitro
Fus-Kujawa, A., Prus, P., Bajdak-Rusinek, K., Teper, P., Gawron, K., Kowalczuk, A., & Sieron, A. L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.701031 · Cited by 186
Boissel, L., Betancur, M., Wels, W. S., Tuncer, H., & Klingemann, H. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.024 · Cited by 166
Zheleva, D. I., Zhelev, N. Z., Fischer, P. M., Duff, S. V., Warbrick, E., Blake, D. G., & Lane, D. P. (2000) · Biochemistry · doi:10.1021/bi992498r · Cited by 87
The p21 and PCNA partnership: A new twist for an old plot
Prives, C., & Gottifredi, V. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7243 · Cited by 78
Reexamination of the Effect of Endotoxin on Cell Proliferation and Transfection Efficiency
Butash, K. A., Natarajan, P., Young, A., & Fox, D. K. (2000) · BioTechniques · doi:10.2144/00293rr04 · Cited by 53
In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
Avci‐Adali, M., Behring, A., Steinle, H., Keller, T., Krajeweski, S., Schlensak, C., & Wendel, H. P. (2014) · Journal of Visualized Experiments · doi:10.3791/51943 · Cited by 48
Warts, cancer and ubiquitylation: lessons from the papillomaviruses.
Howley, P. M. (2006) · Europe PMC (PubMed Central) · Cited by 40
Gharaati-Far, N., Tohidkia, M. R., Dehnad, A., & Omidi, Y. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1355311 · Cited by 37
HPV-Mediated Inactivation of Tumor Suppressor P53
Travé, G., & Zanier, K. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191257 · Cited by 36
mRNA Transfection of Mouse and Human Neural Stem Cell Cultures
McLenachan, S., Zhang, D., Palomo, A. B. A., Edel, M. J., & Chen, F. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083596 · Cited by 30
Nomura, Y., Fukui, C., Morishita, Y., & Haishima, Y. (2017) · Regenerative Therapy · doi:10.1016/j.reth.2017.08.004 · Cited by 29
‘PIPs’ in DNA Polymerase: PCNA Interaction Affairs
Acharya, N., Patel, S. K., Sahu, S. R., & Kumari, P. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200678 · Cited by 27
Rapid Delivery of Nanobodies/VHHs into Living Cells via Expressing In Vitro-Transcribed MRNA
Zhou, X., Hao, R., Chen, C., Su, Z., Zhao, L., Luo, Z., & Xie, W. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.008 · Cited by 26
Liposome-Mediated Transfection of Mammalian Cells
Schenborn, E. T., & Oler, J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-686-x:155 · Cited by 17
Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides
Stoessel, A., Groysbeck, N., Guyot, L., Barret, L., Nominé, Y., Nguekeu-Zebaze, L., Bender, A., Coassolo, L., Lutz, T., Pallaoro, N., et al. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00482 · Cited by 12
Self-citationSmall p53 derived peptide suitable for robust nanobodies dimerization
Dietsch, F., Nominé, Y., Stoessel, A., Kostmann, C., Bonhoure, A., Chatton, B., & Donzeau, M. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.113144 · Cited by 11
Self-citationVigneron, M., Dietsch, F., Bianchetti, L., Dejaegere, A., Nominé, Y., Cordonnier, A., Zuber, G., Chatton, B., & Donzeau, M. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00276 · Cited by 11
Self-citationFaust, C., Beil, C., Dittrich, W., Rao, E., & Langer, T. (2021) · Engineering in Life Sciences · doi:10.1002/elsc.202100065 · Cited by 10
Modular Site-Specific Conjugation of Nanobodies Using Two Co-Associating Tags
Moeglin, É., Barret, L., Chatton, B., & Donzeau, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214405 · Cited by 6
Self-citationNettersheim, J.-A., Janel-Bintz, R., Kuhn, L., & Cordonnier, A. M. (2021) · Journal of Cell Science · doi:10.1242/jcs.258637 · Cited by 3
Ectopic Gene Expression in Macrophages Using in Vitro Transcribed MRNA
Chandra, P., & Philips, J. A. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2857 · Cited by 1
Cited by
Molecular mechanism of IKK catalytic dimer docking to NF-κB substrates
Li, C., Moro, S., Shostak, K., O’Reilly, F. J., Donzeau, M., Graziadei, A., McEwen, A. G., Desplancq, D., Poussin‐Courmontagne, P., Bachelart, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52076-0 · Cited by 64
Self-citationRNA Structure: Past, Future, and Gene Therapy Applications
Haseltine, W. A., Hazel, K., & Patarca, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010110 · Cited by 28
mRNA vaccine in gastrointestinal tumors: Immunomodulatory effects and immunotherapy
Zhang, A., Ji, Q., Sheng, X., & Wu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115361 · Cited by 27
Dabas, R., Navaratnam, N., Iino, H., Saidjalolov, S., Matile, S., Carling, D., Rueda, D., & Kamaly, N. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101425 · Cited by 14
Tracing endogenous proteins in living cells through electrotransfer of mRNA encoding chromobodies
Juncker, T., Richert, L., Masson, M., Zuber, G., Chatton, B., & Donzeau, M. (2024) · Biotechnology Journal · doi:10.1002/biot.202300548 · Cited by 2
Self-citation
Metadata
- Authors
- Juncker, T., Chatton, B., & Donzeau, M.
- Affiliations
- Biotechnologie et Signalisation Cellulaire (FR)
- Corresponding author
- Donzeau, Mariel
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-06-08
- Volume
- 12
- Issue
- 12
- Pages
- 1591
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC10297312
- OpenAlex
- W4380082544
- Cited by
- 6
- References
- 32
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Centre National de la Recherche Scientifique (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
- University of Strasbourg (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
- French Ministry of Research (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
- Ligue Régionale contre le Cancer (CCIR-GE) (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
- Fondation ARC pour la recherche sur le cancer (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
- ITI Innovec (IdEx) (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
- SFRI (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Inactivation Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Molecular Biology Techniques and Applications
- Keywords
- mRNA electroporation, transient transfection, transfection efficiency, nanobodies, protein expression, cell imaging, antigen detection
- MeSH terms
- Cell Line, DNA, Transfection, Gene Transfer Techniques, Electroporation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.